DBIA
AMGN icon

Dumont & Blake Investment Advisors’s Amgen AMGN Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Sell
8,666
-205
-2% -$73.1K 0.76% 29
2025
Q4 		$2.9M Sell
8,871
-50
-0.6% -$15.9K 0.7% 31
2025
Q3 		$2.52M Buy
8,921
+10
+0.1% +$2.9K 0.61% 40
2025
Q2 		$2.49M Buy
8,911
+62
+0.7% +$17.6K 0.65% 38
2025
Q1 		$2.76M Hold
8,849
– – 0.77% 27
2024
Q4 		$2.31M Sell
8,849
-48
-0.5% -$14.2K 0.62% 38
2024
Q3 		$2.87M Sell
8,897
-9,033
-50% -$2.95M 0.76% 30
2024
Q2 		$5.6M Buy
17,930
+8,980
+100% +$2.64M 0.79% 27
2024
Q1 		$2.54M Buy
8,950
+20
+0.2% +$5.85K 0.73% 32
2023
Q4 		$2.57M Sell
8,930
-351
-4% -$95.6K 0.8% 26
2023
Q3 		$2.49M Buy
9,281
+11
+0.1% +$2.75K 0.84% 28
2023
Q2 		$2.06M Sell
9,270
-177
-2% -$41.1K 0.67% 38
2023
Q1 		$2.28M Sell
9,447
-140
-1% -$34.4K 0.77% 31
2022
Q4 		$2.52M Sell
9,587
-74
-0.8% -$19.8K 0.89% 22
2022
Q3 		$2.18M Sell
9,661
-775
-7% -$188K 0.82% 28
2022
Q2 		$2.54M Sell
10,436
-594
-5% -$146K 0.83% 28
2022
Q1 		$2.67M Buy
11,030
+48
+0.4% +$11K 0.73% 32
2021
Q4 		$2.47M Buy
10,982
+37
+0.3% +$7.81K 0.64% 41
2021
Q3 		$2.33M Sell
10,945
-191
-2% -$44K 0.67% 38
2021
Q2 		$2.71M Buy
11,136
+66
+0.6% +$16.2K 0.77% 31
2021
Q1 		$2.75M Sell
11,070
-75
-0.7% -$17.9K 0.85% 27
2020
Q4 		$2.56M Sell
11,145
-522
-4% -$120K 0.88% 23
2020
Q3 		$2.96M Buy
11,667
+173
+2% +$42.9K 1.13% 18
2020
Q2 		$2.71M Sell
11,494
-305
-3% -$69.6K 1.13% 19
2020
Q1 		$2.39M Sell
11,799
-109
-0.9% -$23.8K 1.23% 18
2019
Q4 		$2.87M Buy
11,908
+36
+0.3% +$7.93K 1.13% 19
2019
Q3 		$2.3M Sell
11,872
-1,705
-13% -$327K 0.97% 22
2019
Q2 		$2.5M Buy
13,577
+499
+4% +$89.3K 1.04% 22
2019
Q1 		$2.48M Buy
13,078
+100
+0.8% +$19.1K 1.05% 21
2018
Q4 		$2.53M Sell
12,978
-129
-1% -$25.2K 1.18% 19
2018
Q3 		$2.72M Buy
13,107
+240
+2% +$47.3K 1.06% 23
2018
Q2 		$2.38M Buy
12,867
+150
+1% +$26.5K 1% 23
2018
Q1 		$2.17M Sell
12,717
-80
-0.6% -$14.7K 0.92% 28
2017
Q4 		$2.23M Sell
12,797
-40
-0.3% -$7.08K 0.9% 26
2017
Q3 		$2.39M Sell
12,837
-25
-0.2% -$4.43K 1.02% 25
2017
Q2 		$2.21M Buy
12,862
+40
+0.3% +$6.51K 0.98% 26
2017
Q1 		$2.1M Buy
12,822
+32
+0.3% +$5.32K 0.95% 27
2016
Q4 		$1.87M Buy
12,790
+1,465
+13% +$220K 0.88% 29
2016
Q3 		$1.89M Buy
11,325
+295
+3% +$49.9K 0.93% 27
2016
Q2 		$1.68M Buy
11,030
+70
+0.6% +$10.9K 0.84% 34
2016
Q1 		$1.64M Sell
10,960
-60
-0.5% -$8.91K 0.85% 36
2015
Q4 		$1.79M Sell
11,020
-200
-2% -$31.4K 0.91% 29
2015
Q3 		$1.55M Sell
11,220
-175
-2% -$27.6K 0.84% 38
2015
Q2 		$1.75M Hold
11,395
– – 0.85% 35
2015
Q1 		$1.82M Buy
11,395
+15
+0.1% +$2.36K 0.88% 31
2014
Q4 		$1.81M Sell
11,380
-150
-1% -$23.4K 0.9% 31
2014
Q3 		$1.62M Hold
11,530
– – 0.84% 35
2014
Q2 		$1.36M Sell
11,530
-307
-3% -$35.5K 0.69% 49
2014
Q1 		$1.46M Sell
11,837
-310
-3% -$37.6K 0.76% 44
2013
Q4 		$1.39M Sell
12,147
-1,503
-11% -$171K 0.71% 50
2013
Q3 		$1.53M Sell
13,650
-250
-2% -$27.1K 0.73% 45
2013
Q2 		$1.37M Buy
+13,900
New +$1.44M 0.82% 40

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dumont & Blake Investment Advisors's AMGN Position: Q1 2026 in Review

Dumont & Blake Investment Advisors reduced its Amgen (AMGN) stake by 2.3% in Q1 2026, selling an estimated $73.1K and leaving 8,666 shares worth $3.05M. The position accounts for 0.76% of the portfolio, ranked #29.

Dumont & Blake Investment Advisors first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.6M in Q2 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Dumont & Blake Investment Advisors held 8,666 shares of Amgen worth $3.05M as of Q1 2026.
  • Dumont & Blake Investment Advisors sold 205 Amgen shares in Q1 2026, an estimated $73.1K.
  • Amgen made up 0.76% of Dumont & Blake Investment Advisors's portfolio in Q1 2026, its #29 holding.
  • Dumont & Blake Investment Advisors first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Dumont & Blake Investment Advisors's Amgen position peaked at $5.6M in Q2 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.